Rare disease genomics and justice: overview of a workshop at the Fondation Brocher, 22-24 January 2025.

Authors

Angus Clarke, Ruth Horn, Elena Avram, Siddarth Banka, Felicity Boardman, Victoria Charlton, Mike Drummond, Roseline Favresse, Angeline Ferdinand, David Freis, Ilaria Galasso, Nadine Z Großmann, Meghan Halley, Sasha Henriques, Hadewych Honné, Sofia Douzgou Houge, Salman Kirmani, Tamar Nov Klaiman, Teodora Lalova-Spinks, Charlotta Ingvoldstad Malmgren, Nick Meade, Elena Nicod, Kelly E Ormond, Barbara Prainsack, Hilde Van Esch, Ambroise Wonkam, Sarah L Wynn, Francesca Forzano

Published in

Journal of community genetics. Volume 17. Issue 4. Jul 01, 2026. Epub Jul 01, 2026.

Abstract

Genomics is transforming health care but its implementation raises challenges. This paper reports a 2025 workshop on justice in the implementation of genomics for rare disorders. The workshop goals were to develop a consensus understanding of the problems faced by rare disease patients and families where justice is at stake, to achieve a shared perspective on support for rare disease patients, and to consider the implications for justice in several areas of rare disease genomics, in both research and healthcare. We heard about the diverse experiences and needs of patients. Inequity between different rare diseases is marked. The need for coordination of care for rare disease patients is under-recognized but good models of rare disease care exist. The value of conscientious professionalism to nurture a rare disease mindset needs to be emphasized in the training of each new generation of healthcare students//trainees. The circumstances of different population groups differ systematically. The needs of indigenous and other historically marginalised groups must also be addressed. However, the subordination of individuals to the benefit of the population (i.e. eugenics) must be resisted. Those engaged in genomics projects or diagnostics may need protection from hype and misuse of their personal data, There are different perspectives on the fair allocation of resources to healthcare and research for rare conditions. Health economics and health technology assessment can be practised equitably, so as to meet the challenges of rare disease clinical trials and address the needs of patients and communities.

PMID:
42384115
Bibliographic data and abstract were imported from PubMed on 01 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.